Paxlovid 150 mg filmomhulde tabletten (PF-12345678) en 100 mg filmomhulde tabletten (ritonavir)

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/paxlovid-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Nirmatrelvir and Ritonavir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129406",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOVIDON (E 1208)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MACROGOL 3350",
    "MACROGOL 400",
    "NATRIUMSTEARYLFUMARAAT",
    "NATRIUMSTEARYLFUMARAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "SORBITANMONOLAURAAT (E 493)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NIRMATRELVIR",
    "RITONAVIR"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/01/28",
  "procedure_number": "EMEA/H/C/005973",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1625",
  "additional_monitoring": "Y"
}